49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details
臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00000420 (ClinicalTrials.gov) | June 1997 | 3/11/1999 | Safety of Estrogens in Lupus: Birth Control Pills | Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Oral Contraceptives | Systemic Lupus Erythematosus | Drug: Ortho-Novum 777 | New York University School of Medicine | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);Office of Research on Women's Health (ORWH) | Completed | 18 Years | 39 Years | Female | 350 | Phase 3 | United States |